64 results
Page 3 of 4
DEFM14A
bazxm6 9mkjkz2klxg
21 Dec 18
Proxy related to merger
12:23pm
PREM14A
4zs kxkc52jim23zpz1a
11 Dec 18
Preliminary proxy related to merger
5:23pm
8-K
EX-10.1
o0aq7i gj
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
8-K
EX-99.1
feb2e mw5
14 Aug 18
Avenue Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
9:00am
8-K
EX-99.1
u5qeh5z9
21 May 18
Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative Pain
8:15am
8-K
EX-99.1
tec822
3 May 18
Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
8:00am
DEF 14A
m1zx v4wfy93mbc
30 Apr 18
Definitive proxy
7:02am
10-K
j4juql pxpchwsx2kau
1 Mar 18
Annual report
12:00am
10-Q
a6wm4o5arjg4l5rr
12 May 17
Quarterly report
12:00am
10-12G/A
q2rk3le4dtdzd
13 Mar 17
Registration of securities (amended)
12:00am
10-12G/A
scsfyeghuno0c marmda
6 Mar 17
Registration of securities (amended)
12:00am
10-12G
3y9we4a70mnp2yji8mxu
12 Jan 17
Registration of securities
12:00am
10-12G
EX-10.6
s96ibe5i6wr4q5p6
12 Jan 17
Registration of securities
12:00am
10-12G
EX-10.7
ucs9x87wno
12 Jan 17
Registration of securities
12:00am